Showing titles in Biotechnology

In the past two decades, GMOs have come to dominate the American diet. Advocates hail them as the future of food, an enhanced method of crop breeding that can help feed an ever-increasing global population and adapt to a rapidly changing environment. Critics, meanwhile, call for their banishment, insisting GMOs were designed by overeager scientists and greedy corporations to bolster an industrial food system that forces us to rely on cheap, unhealthy, processed food so they can turn an easy profit.

This scientific writing, which was considered to be the groundwork of evolutionary biology, presented the theory that species developed over a line of originations through a method of natural selection. It imparted evidence that the variety of life resulted from a common descent via a branching model of evolution.

Biochemical engineering integrates the principles of biology, chemistry, and engineering to develop processes for the large-scale production of valuable biochemicals. This interdisciplinary field plays a crucial role in industries such as pharmaceuticals, biotechnology, food and beverage, and environmental engineering. One of the fundamental aspects of biochemical engineering is fermentation, which involves the controlled growth of microorganisms like bacteria, yeast, or fungi to produce desired compounds.

In 2010, scientists led by J. Craig Venter became the first to successfully create "synthetic life" - putting humankind at the threshold of the most important and exciting phase of biological research, one that will enable us to actually write the genetic code for designing new species to help us adapt and evolve for long-term survival. The science of synthetic genomics will have a profound impact on human existence, including chemical and energy generation, health, clean water and food production, environmental control, and possibly even our evolution.

The introduction of new medicines has dramatically improved the quantity and quality of individual and public health, while contributing trillions of dollars to the global economy. In spite of these past successes - and indeed because of them - our ability to deliver new medicines may be quickly coming to an end. Moving from the 20th century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy.

It's the ultimate technology: nanotechnology - the attempt to build ordinary objects from the atoms up, molecule by molecule. So named because its building blocks are the smallest pieces of matter, nanotechnology will give us complete control over the structure of matter, allowing us to build any substance or structure permitted by the Laws of Nature. Placing atoms as if they were bricks, nano-machines could turn grass clippings into prime sirloins - directly, without cows.

Dr. Melanie Laidlaw is a scientist developing the first use of ICSI, short for intracytoplasmic sperm injection. Her collaborator, Dr. Felix Krankenthaler, turns out to have his own ideas about how to implement their new procedure. The wild card is Melanie's new lover, Menachem Dvir, a fellow scientist. This darkly comic ménage à trois plays out not only in bedrooms and labs, but also in test tubes and under the microscope. A Brave New World indeed!

This audiobook, Tomorrow's Medicine, looks at some of the more fascinating areas where technology that could transform health is being developed, including cybernetics, regenerative medicine, nanotechnology, and genetically tailored treatments. Although many of these advances may not be ready to treat humans for many years, some of them may someday profoundly change - and extend - our lives. As exciting as the possibilities are to extend both the length and quality of life, immortality - or at least agelessness - may be forever out of our reach.

Since the birth of civilization, human beings have manipulated other life-forms. We have selectively bred plants and animals for thousands of years to maximize agricultural production and cater to our tastes in pets. The observation of the creation of artificial animal and plant variants was a key stimulant for Charles Darwin's theory of evolution. The ability to directly engineer the genomes of organisms first became possible in the 1970s, when the gene for human insulin was introduced into bacteria.

The Apples, Amazons and Googles of the next few decades will be biotech companies. The tech companies of the last few years have changed how we do things but the businesses driving the biotech revolution are about making life better. These companies will solve many of our most intractable problems: cancer, dementia, diabetes, elderly care, mental health challenges, even power generation and agricultural production. The audiobook explains what biotech is, what is coming next, and in a final section, how interested investors can profit from it.

Ein Blick durch das Schlüsselloch der Forschungslabore und Hightech-Firmen: Woran sie arbeiten, was sie planen, was jetzt schon möglich ist. Spitzenforscher sind sich einig: Auch mit Mitte 90 noch fit zu sein, kann Standard werden. Und 120 Jahre Leben wird für viele Menschen erreichbar – schon für die jetzt geborenen Generationen. Doch was müssen wir tun, um nicht nur länger zu leben, sondern auch länger gesund zu bleiben? Thomas Schulz, langjähriger SPIEGEL-Korrespondent im Silicon Valley, hat mit Konzernchefs und Spitzenforscherinnen, AI-Koryphäen und Medizinerinnen gesprochen.

James T. Bradley introduces important biological principles and the basic procedures used in biotechnology. Various ethical issues - personhood, personal identity, privacy, ethnic discrimination, distributive justice, authenticity and human nature, and the significance of mortality in the human life cycle - are presented in a clear and unbiased manner.

In The Decision Tree, Thomas Goetz proposes a new strategy for thinking about health, one that applies cutting-edge technology and sound science to put us at the center of the equation. An individuals Decision Tree begins with genomics, where $400 and a test tube of spit provides a peek at how your DNA influences your health. It taps self-monitoring and collaborative health tools, where iPhone applications and next-generation monitoring gadgets can help individuals successfully change their behavior, once and for all.

Vaincre le handicap, la maladie et le vieillissement : une enquête inédite sur le l'homme du futur. Remplacer un bras, une jambe par un membre mécatronique ; concevoir des yeux bioniques pour résoudre les problèmes de cécité ; cultiver dans des cochons des organes destinés à être greffés sur l'homme ; donner la vie grâce à un utérus artificiel ; créer ou effacer des souvenirs ; connecter un cerveau à une intelligence artificielle ; freiner le vieillissement en manipulant l'ADN ; congeler un corps pour le réveiller un siècle plus tard...

Jim Geraghty has been a passionate participant in the orphan drug revolution since its inception―a leader in the field as a strategy consultant, biotechnology executive, and venture entrepreneur. His book is in part a history, with eyewitness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen. And it tells deeply personal stories of patients and parents willing to risk untried new therapies.

Caitlin Shetterly discovered the importance of GMOs the hard way. Shortly after she learned that her son had an alarming sensitivity to GMO corn, she was told that she had the same condition, and her family's daily existence changed forever. An expansion of Shetterly's viral Elle article "The Bad Seed", Modified delves deep into the heart of the matter - from the cornfields of Nebraska to the beekeeping conventions in Brussels - to shine a light on the people, the science, and the corporations behind the food we serve ourselves and our families every day.

Already technology enables parents to select some genetic traits for their children, and soon it will be possible to begin to shape ourselves as a species. Countering loud cries of alarm, bioethics expert Ronald Green explains why our fears about genetic engineering are overblown and how we can move forward responsibly to create a better future.

Life on earth is facing unprecedented challenges from global warming, war, and mass extinctions. The plight of seeds is a less visible but no less fundamental threat to our survival. Seeds are at the heart of the planet's life-support systems. Their power to regenerate and adapt are essential to maintaining our food supply and our ability to cope with a changing climate. Environmental journalist Claire Hope Cummings exposes the stories behind the rise of industrial agriculture and plant biotechnology, the fall of public interest science, and the folly of patenting seeds.

Animals make for terrible technology. The technological use of animals - making food, drugs, clothing, and cosmetics out of animal material - will cease. After Meat explains the fundamental limits of animal technology in terms of physics and biology. Replacement technology such as microbial fermentation will surpass those limits. Eventually, we’ll have food that is better in every way - in terms of taste, cost, nutrition, resource consumption, and ethics - because we won't use animals to produce it.

In this lecture, Professor Kahn will examine the state of health care and biomedical research in the US and around the globe, through the lens of ethics. The lecture will start with some historical context and examples from bioethics, and draw some parallels from the past for the current state of our public discussions on a range of controversial bioethics issues.